Xiaolong Tang

Xiaolong Tang

Auto-generated profile, based on publicly available information

Xiaolong Tang

The Second Department of Gastrointestinal Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NGNoha Saleh Gholais
Noha Saleh Gholais
CSChunrui Shi
Chunrui Shi
JZJing Zhang
Jing Zhang
BLBei Liao
Bei Liao
RARowida A. Albarmaqi
Rowida A. Albarmaqi
LMLeyuan Mi
Leyuan Mi
Background. JinGuanLan (JGL) formula is a traditional Chinese medicine (TCM) developed by the Department of Pharmacology at the First Hospital of Lanzhou University. The network pharmacology approach was applied to determine the potential active compounds, therapeutic targets, and main pathways of the JGL formula to evaluate its application value in acne vulgaris. Methods. Data on the active compounds and their related targets were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Acne vulgaris-related targets were searched from the Online Mendelian Inheritance in Man (OMIM) database, GeneCards Database, Comparative Toxicogenomics Database (CTD), Therapeutic Target Database (TTD), and DisGeNET Database. Targets intersecting between JGL- and acne vulgaris-related targets were chosen as potential therapeutic targets. The protein-protein interaction (PPI) network of potential therapeutic targets was visualized using Cytoscape software based on the PPI data collected from the STRING database. Three topological features, namely, Degree, MCC, and EPC of each node in the PPI network were calculated using the cytoHubba plugin of Cytoscape to excavate the core targets. R program was used for the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of the potential therapeutic targets. Finally, the compoundtargetpathway network was constructed. Result. Among the 148 active compounds that were identified, quercetin and kaempferol showed the highest degree of target interaction and thus may play essential roles in the pharmacological effect of the JGL formula for acne treatment. Among the 97 potential therapeutic targets that were screened out, the 6 core targets were TNF, JUN, IL6, STAT3, MAPK1, and MAPK3. A total of 2260 terms of GO enrichment analysis were obtained, including 2090 for biological processes (BP), 37 for cellular components (CC), and 133 for molecular function (MF). A total of 156 enriched KEGG pathways were identified, including TNF, IL-17, Th17cell differentiation, MAPK, PI3K-Akt, T cell receptor, and Toll-like receptor signalling pathways. Conclusion. This work showed that the JGL formula might reverse the pathological changes associated with acne vulgaris through its antiinflammatory effect and regulate the excessive lipogenesis in sebaceous glands via different signalling pathways. This new drug has application value and is worthy of further research and development.

20 April 2023 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
XTXiaolong Tang
Xiaolong Tang
XRXiangqing Ren
Xiangqing Ren
THTian Huang
Tian Huang
YMYandong Miao
Yandong Miao
WHWuhua Ha
Wuhua Ha
DMDenghai Mi
Denghai Mi
Background. Hepatocellular carcinoma (HCC) remains a challenging medical problem. Cuproptosis is a novel form of cell death that plays a crucial role in tumorigenesis, angiogenesis, and metastasis. However, it remains unclear whether cuproptosis-related genes (CRGs) influence the outcomes and immune microenvironment of HCC patients. Method. From The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases, we obtained the mRNA expression file and related clinical information of HCC patients. We selected 19 CRGs as candidate genes for this study according to previous literature. We performed a differential expression analysis of the 19 CRGs between malignant and precancerous tissue. Based on the 19 CRGs, we enrolled cluster analysis to identify cuproptosis-related subtypes of HCC patients. A prognostic risk signature was created utilizing univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses. We employed independent and stratification survival analyses to investigate the predictive value of this model. The functional enrichment features, mutation signatures, immune profile, and response to immunotherapy of HCC patients were also investigated according to the two molecular subtypes and the prognostic signature. Results. We found that 17 CRGs significantly differed in HCC versus normal samples. Cluster analysis showed two distinct molecular subtypes of cuproptosis. Cluster 1 is preferentially related to poor prognosis, high activity of immune response signaling, high mutant frequency of TP53, and distinct immune cell infiltration versus cluster 2. Through univariate and LASSO Cox regression analyses, we created a cuproptosis-related prognostic risk signature containing LIPT1, DLAT, MTF1, GLS, and CDKN2A. High-risk HCC patients were shown to have a worse prognosis. The risk signature was proved to be an independent predictor of prognosis in both the TCGA and ICGC datasets, according to multivariate analysis. The signature also performed well in different stratification of clinical features. The immune cells, which included regulatory T cells (Treg), B cells, macrophages, mast cells, NK cells, and aDCs, as well as immune functions containing cytolytic activity, MHC class I, and type II IFN response, were remarkably distinct between the high-risk and low-risk groups. The tumor immune dysfunction and exclusion (TIDE) score suggested that high-risk patients had a higher response rate to immune checkpoint inhibitors than low-risk patients. Conclusion. This research discovered the potential prognostic and immunological significance of cuproptosis in HCC, improved the understanding of cuproptosis, and may deliver new directions for developing more efficacious therapeutic techniques for HCC patients.

2 July 2025 in International Journal of Surgery
Verified
Journal Article
Open access
ZZZheng Msc Zhang
Zheng Msc Zhang
ZZZheng-Chao Zhang
Zheng-Chao Zhang
SZShu-Ping Zhang
Shu-Ping Zhang
WLWen-Yu Msc Luan
Wen-Yu Msc Luan
SHShuang Msc Han
Shuang Msc Han
YMYandong Miao
Yandong Miao
This study systematically evaluated the effectiveness of three artificial intelligence (AI) tools – ChatGPT-4o, Claude 3.5, and DeepSeek – in disseminating colorectal cancer screening guidelines to nonmedical populations. Using uniform instructions aligned with the Chinese Society of Clinical Oncology 2024 standards, the AI-generated content was analyzed for accuracy, clarity, and rigor, supplemented by a cross-evaluation mechanism to quantify performance. Key findings revealed that DeepSeek demonstrated superior regional adaptability and logical rigor, while requiring improvements in threshold accuracy; ChatGPT-4o exhibited outdated starting age criteria and oversimplified high-risk population screening protocols; and Claude 3.5 provided a comprehensive framework but lacked critical implementation details. All tools effectively translated complex medical guidelines into accessible language, underscoring AI’s potential in public health education. However, outputs necessitated clinical validation and ethical oversight to mitigate data biases. The study emphasizes AI’s role as an auxiliary tool for medical knowledge dissemination, advocating for continuous algorithmic optimization, multidisciplinary collaboration, and dynamic regulatory mechanisms to ensure alignment with evolving medical standards while balancing scientific precision and public accessibility.

17 February 2022 in IET Systems Biology
Verified
Journal Article
Open access
PDF file
YMYandong Miao
Yandong Miao
BSBin Su
Bin Su
XTXiaolong Tang
Xiaolong Tang
JWJiangtao Wang
Jiangtao Wang
WQWuxia Quan
Wuxia Quan
DMDenghai Mi
Denghai Mi
N6‐methyladenosine (m 6 A) RNA methylation is correlated with carcinogenesis and dynamically possessed through the m 6 A RNA methylation regulators. This paper aimed to explore 13 m 6 A RNA methylation regulators' role in gastrointestinal cancer (GIC) and determine the risk model and prognosis value of m 6 A RNA methylation regulators in GIC. We used several bioinformatics methods to identify the differential expression of m 6 A RNA methylation regulators in GIC, constructed a prognostic model, and carried out functional enrichment analysis. Eleven of 13 m 6 A RNA methylation regulators were differentially expressed in different clinicopathological characteristics of GIC, and m 6 A RNA methylation regulators were nearly associated with GIC. We constructed a risk model based on five m 6 A RNA methylation regulators (METTL3, FTO, YTHDF1, ZC3H13, and WTAP); the risk score is an independent prognosis biomarker. Moreover, the five m 6 A RNA methylation regulators can also forecast the 1‐, 3‐ and 5‐year overall survival through a nomogram. Furthermore, four hallmarks of oxidative phosphorylation, glycolysis, fatty acid metabolism, and cholesterol homoeostasis gene sets were significantly enriched in GIC. m 6 A RNA methylation regulators were related to the malignant clinicopathological characteristics of GIC and may be used for prognostic stratification and development of therapeutic strategies.

13 March 2020 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
XTXiaolong Tang
Xiaolong Tang
QHQingsi He
Qingsi He
GSGuorui Sun
Guorui Sun
HQHui Qu
Hui Qu
JLJia Liu
Jia Liu
YLYahang Liang
Yahang Liang

16 October 2026 in Medicine
Verified
Journal Article
Open access
JZJinkai Zhou
Jinkai Zhou
HZHe Zhou
He Zhou
JXJiayu Xu
Jiayu Xu
MWMaohua Wang
Maohua Wang
LLLei Liu
Lei Liu
XTXiaolong Tang
Xiaolong Tang
Background: Colorectal cancer (CRC), is a highly prevalent malignant tumor worldwide, and early screening is key to improving its prognosis. Currently, CRC screening research is growing exponentially, but its core research hotspots, evolutionary trends, and interdisciplinary features are not clear. In this study, we used bibliometric analysis to analyze the distribution of literature, research hotspots, and cutting-edge developments in the field of CRC screening worldwide, and to provide a scientific basis for optimizing screening strategies. Methods: Publications on CRC screening from 2015 to 2024 were retrieved from the Web of Science Core Collection. VOSviewer (v1.6.20), RStudio (v4.4.1), and CiteSpace (v6.4.2) were used for bibliometric and visual analyses. The main analyses included publication trends, countries, authors, journals, references, and keywords. Result: A total of 3245 publications were included in the analysis. Global publications on CRC screening showed a steady upward trend over the past decade, with an annual growth rate of 2.17%. The United States contributed the highest number of publications, and the University of North Carolina ranked as the most productive institution. GASTROENTEROLOGY and GUT were the most frequently cited journals in this field. Lansdorp‑Vogelaar I was among the most prolific authors. The most cited article was “CRC screening for average-risk adults: 2018 guideline update from the American Cancer Society.” Keyword analysis showed that the research hotspots in this field included colonoscopy, biomarker, adenoma detection rate, artificial intelligence, etc. Conclusion: Current research in CRC screening focuses on traditional screening methods, population-related factors, and emerging technologies, particularly artificial intelligence. Stronger international collaboration and interdisciplinary studies are needed to advance the field.